These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38447636)

  • 1. The Ideal Heart Rate for Heart Failure and Ejection Fraction > 40%: Both Myth and Magic?
    Packer M
    J Card Fail; 2024 Jun; 30(6):863-865. PubMed ID: 38447636
    [No Abstract]   [Full Text] [Related]  

  • 2. Heart Rate and Heart Failure With Preserved Ejection Fraction: Time to Slow β-Blocker Use?
    Meyer M; LeWinter MM
    Circ Heart Fail; 2019 Aug; 12(8):e006213. PubMed ID: 31525068
    [No Abstract]   [Full Text] [Related]  

  • 3. Atrial Fibrillation and Heart Failure with Preserved Ejection Fraction: Two Chronic Troublemakers.
    Kim IC
    Heart Fail Clin; 2021 Jul; 17(3):377-386. PubMed ID: 34051970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology of Atrial Fibrillation and Heart Failure: Dangerous Interactions.
    Sugumar H; Nanayakkara S; Prabhu S; Voskoboinik A; Kaye DM; Ling LH; Kistler PM
    Cardiol Clin; 2019 May; 37(2):131-138. PubMed ID: 30926014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased pulse wave velocity and not reduced ejection fraction is associated with impaired baroreflex control of heart rate in congestive heart failure.
    Radaelli A; Castiglioni P; Balestri G; Cesana F; De Carlini C; Soriano F; Azzellino A; Di Rienzo M; Paolini G; Ferrari AU; Mancia G
    J Hypertens; 2010 Sep; 28(9):1908-12. PubMed ID: 20577129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heartbeat: risk of stroke in patients with heart failure.
    Otto CM
    Heart; 2020 Apr; 106(8):549-551. PubMed ID: 32217732
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic Significance of Resting Heart Rate and Use of β-Blockers in Atrial Fibrillation and Sinus Rhythm in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Swedish Heart Failure Registry.
    Li SJ; Sartipy U; Lund LH; Dahlström U; Adiels M; Petzold M; Fu M
    Circ Heart Fail; 2015 Sep; 8(5):871-9. PubMed ID: 26243796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refining Classification of Heart Failure Based on Ejection Fraction.
    Fonarow GC
    JACC Heart Fail; 2017 Nov; 5(11):808-809. PubMed ID: 29096789
    [No Abstract]   [Full Text] [Related]  

  • 9. Heart rate and the risk of adverse outcomes in patients with heart failure with preserved ejection fraction.
    O'Neal WT; Sandesara PB; Samman-Tahhan A; Kelli HM; Hammadah M; Soliman EZ
    Eur J Prev Cardiol; 2017 Jul; 24(11):1212-1219. PubMed ID: 28482692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of stroke volume on prognostic outcome in patients with atrial fibrillation and concomitant heart failure with preserved ejection fraction.
    Hayashi H; Abe Y; Morita Y; Yamaji Y; Nakane E; Haruna Y; Haruna T; Inoko M
    J Cardiol; 2019 Apr; 73(4):307-312. PubMed ID: 30587456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Prevalence, Incidence, and Outcomes of Heart Failure with Preserved Ejection Fraction.
    Cho DH; Yoo BS
    Heart Fail Clin; 2021 Jul; 17(3):315-326. PubMed ID: 34051964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detrended fluctuation analysis can detect the impairment of heart rate regulation in patients with heart failure with preserved ejection fraction.
    Mizobuchi A; Osawa K; Tanaka M; Yumoto A; Saito H; Fuke S
    J Cardiol; 2021 Jan; 77(1):72-78. PubMed ID: 32826140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac diastolic and autonomic dysfunction are aggravated by central chemoreflex activation in heart failure with preserved ejection fraction rats.
    Toledo C; Andrade DC; Lucero C; Arce-Alvarez A; Díaz HS; Aliaga V; Schultz HD; Marcus NJ; Manríquez M; Faúndez M; Del Rio R
    J Physiol; 2017 Apr; 595(8):2479-2495. PubMed ID: 28181258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rate pressure product and the components of heart rate and systolic blood pressure in hospitalized heart failure patients with preserved ejection fraction: Insights from ASCEND-HF.
    Verma AK; Sun JL; Hernandez A; Teerlink JR; Schulte PJ; Ezekowitz J; Voors A; Starling R; Armstrong P; O'Conner CM; Mentz RJ
    Clin Cardiol; 2018 Jul; 41(7):945-952. PubMed ID: 29781109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart rate during exercise: mechanisms, behavior, and therapeutic and prognostic implications in heart failure patients with reduced ejection fraction.
    Paolillo S; Agostoni P; De Martino F; Ferrazzano F; Marsico F; Gargiulo P; Pirozzi E; Marciano C; Dellegrottaglie S; Perrone Filardi P
    Heart Fail Rev; 2018 Jul; 23(4):537-545. PubMed ID: 29926282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with outcome in heart failure with preserved ejection fraction: findings from the Irbesartan in Heart Failure with Preserved Ejection Fraction Study (I-PRESERVE).
    Komajda M; Carson PE; Hetzel S; McKelvie R; McMurray J; Ptaszynska A; Zile MR; Demets D; Massie BM
    Circ Heart Fail; 2011 Jan; 4(1):27-35. PubMed ID: 21068341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to optimal heart rate control in heart failure with reduced ejection fraction: insight from a survey of heart rate in heart failure in Sweden (HR-HF study).
    Fu M; Ahrenmark U; Berglund S; Lindholm CJ; Lehto A; Broberg AM; Tasevska-Dinevska G; Wikstrom G; Ågard A; Andersson B;
    Clin Res Cardiol; 2017 Dec; 106(12):960-973. PubMed ID: 28795299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale and design of the phase 2b clinical trials to study the effects of the partial adenosine A1-receptor agonist neladenoson bialanate in patients with chronic heart failure with reduced (PANTHEON) and preserved (PANACHE) ejection fraction.
    Voors AA; Shah SJ; Bax JJ; Butler J; Gheorghiade M; Hernandez AF; Kitzman DW; McMurray JJV; Wirtz AB; Lanius V; van der Laan M; Solomon SD
    Eur J Heart Fail; 2018 Nov; 20(11):1601-1610. PubMed ID: 30225882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise training improves cardiac autonomic control, cardiac function, and arrhythmogenesis in rats with preserved-ejection fraction heart failure.
    Andrade DC; Arce-Alvarez A; Toledo C; Díaz HS; Lucero C; Schultz HD; Marcus NJ; Del Rio R
    J Appl Physiol (1985); 2017 Sep; 123(3):567-577. PubMed ID: 28620053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction.
    Solomon SD; Claggett B; Lewis EF; Desai A; Anand I; Sweitzer NK; O'Meara E; Shah SJ; McKinlay S; Fleg JL; Sopko G; Pitt B; Pfeffer MA;
    Eur Heart J; 2016 Feb; 37(5):455-62. PubMed ID: 26374849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.